CDMO has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
CDMO has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Avid Bioservices's enterprise value is $748.2 Mil. Avid Bioservices's EBITDA for the trailing twelve months (TTM) ended in Jan. 2024 was $-7.8 Mil. Therefore, Avid Bioservices's EV-to-EBITDA for today is -95.57.
The historical rank and industry rank for Avid Bioservices's EV-to-EBITDA or its related term are showing as below:
During the past 13 years, the highest EV-to-EBITDA of Avid Bioservices was 979.12. The lowest was -298.77. And the median was -3.55.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
As of today (2024-05-18), Avid Bioservices's stock price is $9.12. Avid Bioservices's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jan. 2024 was $-0.275. Therefore, Avid Bioservices's PE Ratio for today is At Loss.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.
The historical data trend for Avid Bioservices's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Avid Bioservices Annual Data | |||||||||||||||||||||
Trend | Apr14 | Apr15 | Apr16 | Apr17 | Apr18 | Apr19 | Apr20 | Apr21 | Apr22 | Apr23 | |||||||||||
EV-to-EBITDA | Get a 7-Day Free Trial | -91.58 | -45.49 | 79.31 | 44.82 | 108.55 |
Avid Bioservices Quarterly Data | ||||||||||||||||||||
Apr19 | Jul19 | Oct19 | Jan20 | Apr20 | Jul20 | Oct20 | Jan21 | Apr21 | Jul21 | Oct21 | Jan22 | Apr22 | Jul22 | Oct22 | Jan23 | Apr23 | Jul23 | Oct23 | Jan24 | |
EV-to-EBITDA | Get a 7-Day Free Trial | 98.42 | 108.55 | 117.70 | 915.16 | -75.85 |
For the Biotechnology subindustry, Avid Bioservices's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Biotechnology industry and Healthcare sector, Avid Bioservices's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Avid Bioservices's EV-to-EBITDA falls into.
Avid Bioservices's EV-to-EBITDA for today is calculated as:
EV-to-EBITDA | = | Enterprise Value (Today) | / | EBITDA (TTM) |
= | 748.207 | / | -7.829 | |
= | -95.57 |
Avid Bioservices's current Enterprise Value is $748.2 Mil.
Avid Bioservices's EBITDA for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-7.8 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Avid Bioservices (NAS:CDMO) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Avid Bioservices's PE Ratio for today is calculated as:
PE Ratio | = | Share Price (Today) | / | Earnings per Share (Diluted) (TTM) |
= | 9.12 | / | -0.275 | |
= | At Loss |
Avid Bioservices's share price for today is $9.12.
Avid Bioservices's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.275.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.
Please read Which price ratio outperforms the enterprise multiple?
Thank you for viewing the detailed overview of Avid Bioservices's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
Matthew R. Kwietniak | officer: Chief Commercial Officer | 14191 MYFORD ROAD, TUSTIN CA 92780 |
Richard A. Richieri | officer: Chief Operations Officer | 14191 MYFORD ROAD, TUSTIN CA 92780 |
Daniel Ryan Hart | officer: Chief Financial Officer | 2642 MICHELLE DR., SUITE 200, TUSTIN CA 62780 |
Mark R Ziebell | officer: V.P., General Counsel | 14282 FRANKLIN AVENUE, TUSTIN CA 92780 |
Richard B Hancock | director | 14282 FRANKLIN AVE., TUSTIN CA 92780 |
Joseph Carleone | director | 3883 HOWARD HUGHES PKWY, SUITE 700, LAS VEGAS NV 89169 |
Nicholas Stewart Green | director, officer: President & CEO | 2642 MICHELLE DRIVE, SUITE 200, TUSTIN CA 92780 |
Gregory Sargen | director | |
Esther M. Alegria | director | 2642 MICHELLE DRIVE, SUITE 200, TUSTIN CA 92780 |
Mark R Bamforth | director | 500 KENDALL ST., CAMBRIDGE MA 02142 |
Jeanne Thoma | director | C/O ANI PHARMACEUTICALS, INC., 210 MAIN STREET WEST, BAUDETTE MN 56623 |
Patrick D Walsh | director | 14282 FRANKLIN AVE., TUSTIN CA 92780 |
Catherine J Mackey | director | 3595 JOHN HOPKINS COURT, SAN DIEGO CA 92121 |
Joel Mccomb | director | 9885 TOWNE CENTRE DRIVE, SAN DIEGO CA 92121 |
Stephen Michael Hedberg | officer: Principal Fin. & Acct. Officer | 2642 MICHELLE DRIVE, SUITE 200, TUSTIN CA 92780 |
From GuruFocus
By Value_Insider Value_Insider • 11-29-2022
By GuruFocus Research • 12-19-2023
By GuruFocusNews GuruFocusNews • 07-03-2022
By Marketwired • 06-21-2023
By Value_Insider Value_Insider • 11-02-2022
By GuruFocusNews GuruFocusNews • 06-24-2022
By GuruFocusNews GuruFocusNews • 06-13-2022
By PurpleRose PurpleRose • 07-14-2022
By Marketwired • 09-26-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.